IDH2 and neoplasm: When such tumours arise as solitary lesions in the medullary cavity (central CS) or more rarely in the periosteum, ~50% harbour either a somatic IDH1 (isocitrate dehydrogenase 1) or IDH2 heterozygous mutation2.